If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. ISIN CH0012221716
|
1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
|
|
Investor AB
|
|
2. Check the Appropriate Box if a Member of a Group (See Instructions):
|
|
|
(a) [ ]
(b) [X]
|
|
3. SEC Use Only
|
4. Source of Funds (See Instructions): WC
|
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): Not Applicable
|
6. Citizenship or Place of Organization: Kingdom of Sweden
|
|
|
Number of
|
7. Sole Voting Power:
|
259,295,142*
|
|
|
Shares Beneficially
|
8. Shared Voting Power:
|
0*
|
|
|
Owned by
|
|
|
|
|
Each Reporting
|
9. Sole Dispositive Power:
|
259,295,142*
|
|
|
Person With
|
10. Shared Dispositive Power:
|
0*
|
|
|
|
|
|
11. Aggregate Amount Beneficially Owned by Each Reporting Person: 259,295,142*
|
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):
|
|
Not Applicable
|
|
13. Percent of Class Represented by Amount in Row (11): 12.2%*
|
14. Type of Reporting Person (See Instructions): HC
|
|
|
|
|
|
|
|
|
|
*As of March 6, 2020 (the “Filing
Date”), Investor AB, a limited liability company incorporated under the laws of the Kingdom of Sweden (the “Reporting
Person”), through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the
disposition of all securities of ABB Ltd, a limited liability company incorporated under the laws of Switzerland (the “Company”),
held by the Reporting Person. Based upon the Company’s disclosure as set forth on its investor relations web page, viewed
as of the Filing Date, as of December 31, 2019, there were 2,133,501,111 issued and outstanding Registered Shares, par value CHF
0.12 (the “Registered Shares”). Thus, for the purposes of Rule 13d-3 under the Securities Exchange Act of 1934
(the “Act”), the Reporting Person is deemed to beneficially own 12.2% of the Registered Shares issued and outstanding
as of the Filing Date. In addition to the Registered Shares held by the Reporting Person and deemed beneficially owned by the
Reporting Person, executive officers and directors of the Reporting Person (collectively, the “Executive Officers and
Directors”) hold Registered Shares. Two of the Executive Officers and Directors are members of the Company’s Board
of Directors and hold Registered Shares. Pursuant to Rule 13d-4 under the Act, the Reporting Person disclaims the beneficial ownership
of any Registered Shares held by the Executive Officers and Directors.
Item 2. Identity
and Background.
This
statement is being filed by Investor AB (the “Reporting Person”), a limited liability company incorporated under the
laws of the Kingdom of Sweden, whose business address is Arsenalsgatan 8c, S-103 32 Stockholm, Sweden. The Reporting Person is
a publicly held limited liability company engaged principally in business as a diversified industrial holding company. The Reporting
Person, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition
of all securities of the Company held by the Reporting Person.
During
the last five years, neither the Reporting Person nor any executive officers and directors of the Reporting Person (collectively,
the “Executive Officers and Directors”) as set forth on Schedule A annexed hereto, to the best of the Reporting Person’s
knowledge and belief, have been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), or
have been a party to any civil proceeding commenced before a judicial or administrative body of competent jurisdiction as a result
of which the Reporting Person, or any of the Executive Officers and Directors, was, or now is, subject to a judgment, decree,
or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities
laws, or finding any violation with respect to such laws.
Item 3. Source
and Amount of Funds or Other Consideration.
Item
3 of this Schedule 13D is hereby amended and restated in its entirety as follows:
All
of the Reporting Person’s funds used in making the purchases of the Registered Shares described in this Schedule 13D came
from the general assets of the Reporting Person. The aggregate amount of funds used to make the purchases of the Registered Shares
as set forth in Item 5 of this Schedule 13D Amendment Number 6 was approximately USD $100,485,000. The Registered Shares were
purchased using Swiss Francs. For the purposes of this Schedule 13D Amendment Number 6, a conversion rate of USD 1.00 for each
CHF 0.95 was used.
Item 5. Interest
in Securities of the Issuer.
Item 5 of this Schedule 13D is hereby amended
and restated in its entirety as follows:
As of March 6, 2020 (the
“Filing Date”), the Reporting Person, through one or more intermediate entities, possesses the sole power to vote
and the sole power to direct the disposition of all securities of the Company held by the Reporting Person. Based upon the Company’s
disclosure as set forth on its investor relations web page, viewed as of the Filing Date, as of December 31, 2019, there were
2,133,501,111 issued and outstanding Registered Shares. Thus, for the purposes of Rule 13d-3 under the Securities Exchange Act
of 1934 (the “Act”), the Reporting Person is deemed to beneficially own 12.2% of the Registered Shares issued and
outstanding as of the Filing Date.
In
addition to the Registered Shares held by the Reporting Person and deemed beneficially owned by the Reporting Person, Executive
Officers and Directors hold Registered Shares. Two of the Executive Officers and Directors are members of the Company’s Board
of Directors and hold Registered Shares. Pursuant to Rule 13d-4 under the Act, the Reporting Person disclaims the beneficial ownership
of any Registered Shares held by the Executive Officers and Directors.
The
following table sets forth the purchase transactions (each of which were purchases effected in an ordinary brokerage transaction)
which required the filing of this Schedule 13D Amendment Number 6 with respect to the Registered Shares, or securities convertible
into, exercisable for, or exchangeable for, Registered Shares, by the Reporting Person, or any person or entity controlled by
the Reporting Person, or any person or entity for which the Reporting Person possesses voting or investment control over the securities
thereof:
Transaction Date
|
Number of Registered Shares
|
Purchase Price Per Share in US Dollars*
|
February 10, 2020
|
210,000
|
$25.08
|
February 11, 2020
|
210,000
|
$25.35
|
February 13, 2020
|
210,000
|
$25.15
|
February 14, 2020
|
210,000
|
$25.10
|
February 18, 2020
|
160,000
|
$24.96
|
February 24, 2020
|
230,000
|
$23.57
|
February 25, 2020
|
230,000
|
$23.40
|
February 26, 2020
|
230,000
|
$23.42
|
February 27, 2020
|
240,000
|
$22.79
|
February 28, 2020
|
490,000
|
$21.86
|
March 2, 2020
|
490,000
|
$21.78
|
March 3, 2020
|
490,000
|
$22.25
|
March 4, 2020
|
490,000
|
$22.03
|
March 5, 2020
|
490,000
|
$21.63
|
*The Registered Shares were purchased
using Swiss Francs. For the purposes of this Schedule 13D Amendment Number 6, a conversion rate of USD 1.00 for each CHF 0.95
was used.
Other
than as set forth in the table above, there were no transactions in the Registered Shares, or securities convertible into, exercisable
for, or exchangeable for, Registered Shares, by the Reporting Person or any other person or entity controlled by Reporting Person,
or any person or entity for which the Reporting Person possesses voting or investment control, during the period commencing sixty
(60) days prior to March 5, 2020, the date of the event which required the filing of this Schedule 13D, and ending on the Filing
Date.
The
Reporting Person has sold put options that permit the holder of the put option to
require the Reporting Person to purchase the Registered Shares in accordance with the terms of the applicable put option. The
Reporting Person may sell, on one or more occasions, additional put options.
Nothing
set forth herein shall be construed as an admission by the Reporting Person, or any other person or entity, that the Reporting
Person, or any other person or entity, is the beneficial owner of any of the Company’s securities that are beneficially owned
by any other person or entity for the purposes of Section 13(d) of the Act, or for any other purposes.
Except
as otherwise described herein, no contracts, arrangements, understandings, or similar relationships exist with respect to the
securities of the Company between the Reporting Person, or any other person or entity controlled by Reporting Person, or any person
or entity for which the Reporting Person possesses voting or investment control, and any other person or entity.
[signatures follow on the next page]
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
March 6, 2020
|
|
|
|
|
|
INVESTOR AB
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Johan Forssell
|
|
|
|
Name: Johan Forssell
|
|
|
|
Title: Authorized Signatory
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Petra Hedengran
|
|
|
|
Name: Petra Hedengran
|
|
|
|
Title: Authorized Signatory
|
|
|
|
|
|
|
|
|
|
|
Attention: Intentional misstatements or omissions
of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).
SCHEDULE A
EXECUTIVE OFFICERS AND DIRECTORS
Name
|
Position
|
Citizenship
|
Present Principal Occupation
|
Business Address
|
Jacob Wallenberg
|
Chairman
|
Swedish
|
Chairman of the Board
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Johan Forssell
|
CEO, Director
|
Swedish
|
Chief Executive Officer, President, and Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Gunnar Brock
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Tom Johnstone
|
Director
|
British
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Magdalena
Gerger
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Grace Reksten Skaugen
|
Director
|
Norwegian
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Hans Stråberg
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Lena Treschow Torell
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Marcus Wallenberg
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 4, SE-103 22 Stockholm, Sweden
|
Sara Mazur
|
Director
|
Swedish
|
Director
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Petra Hedengran
|
Managing Director
|
Swedish
|
General Counsel and Head of Corporate Governance and Compliance
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Helena Saxon
|
Managing Director
|
Swedish
|
Chief Financial Officer
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Daniel Nodhäll
|
Managing Director
|
Swedish
|
Head of Listed Core Investments
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|
Viveka Hirdman-Ryrberg
|
Managing Director
|
Swedish
|
Head of Corporate Communication and Sustainability
|
Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden
|